142 related articles for article (PubMed ID: 8806853)
1. Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells.
Kulp KS; Vulliet PR
Toxicol Appl Pharmacol; 1996 Aug; 139(2):356-64. PubMed ID: 8806853
[TBL] [Abstract][Full Text] [Related]
2. Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells.
Kulp KS; Green SL; Vulliet PR
Exp Cell Res; 1996 Nov; 229(1):60-8. PubMed ID: 8940249
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell lines.
Hoyes KP; Hider RC; Porter JB
Cancer Res; 1992 Sep; 52(17):4591-9. PubMed ID: 1511427
[TBL] [Abstract][Full Text] [Related]
5. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
Richardson D; Ponka P; Baker E
Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
[TBL] [Abstract][Full Text] [Related]
6. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
Chaston TB; Lovejoy DB; Watts RN; Richardson DR
Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo.
Jiang XP; Wang F; Yang DC; Elliott RL; Head JF
Anticancer Res; 2002; 22(5):2685-92. PubMed ID: 12529982
[TBL] [Abstract][Full Text] [Related]
8. Iron chelator-induced growth arrest and cytochrome c-dependent apoptosis in immortalized and malignant oral keratinocytes.
Lee SK; Lee JJ; Lee HJ; Lee J; Jeon BH; Jun CD; Lee SK; Kim EC
J Oral Pathol Med; 2006 Apr; 35(4):218-26. PubMed ID: 16519769
[TBL] [Abstract][Full Text] [Related]
9. Mimosine arrests the cell cycle after cells enter S-phase.
Hughes TA; Cook PR
Exp Cell Res; 1996 Feb; 222(2):275-80. PubMed ID: 8598214
[TBL] [Abstract][Full Text] [Related]
10. Radiation sensitization of mammalian cells by metal chelators.
Cook J
Radiat Res; 2001 Feb; 155(2):304-10. PubMed ID: 11175665
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.
Wiesinger JA; Buwen JP; Cifelli CJ; Unger EL; Jones BC; Beard JL
J Neurochem; 2007 Jan; 100(1):167-79. PubMed ID: 17227437
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.
Brodie C; Siriwardana G; Lucas J; Schleicher R; Terada N; Szepesi A; Gelfand E; Seligman P
Cancer Res; 1993 Sep; 53(17):3968-75. PubMed ID: 8358725
[TBL] [Abstract][Full Text] [Related]
14. p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine.
Alpan RS; Pardee AB
Cell Growth Differ; 1996 Jul; 7(7):893-901. PubMed ID: 8809407
[TBL] [Abstract][Full Text] [Related]
15. Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma.
Brard L; Granai CO; Swamy N
Gynecol Oncol; 2006 Jan; 100(1):116-27. PubMed ID: 16203029
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of histone H1 kinase expression by mimosine, a plant amino acid.
Feldman ST; Schönthal A
Cancer Res; 1994 Jan; 54(2):494-8. PubMed ID: 8275487
[TBL] [Abstract][Full Text] [Related]
17. Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin.
Hoke EM; Maylock CA; Shacter E
Free Radic Biol Med; 2005 Aug; 39(3):403-11. PubMed ID: 15993339
[TBL] [Abstract][Full Text] [Related]
18. Mimosine differentially inhibits DNA replication and cell cycle progression in somatic cells compared to embryonic cells of Xenopus laevis.
Wang Y; Zhao J; Clapper J; Martin LD; Du C; DeVore ER; Harkins K; Dobbs DL; Benbow RM
Exp Cell Res; 1995 Mar; 217(1):84-91. PubMed ID: 7867725
[TBL] [Abstract][Full Text] [Related]
19. The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine.
Gharagozloo M; Khoshdel Z; Amirghofran Z
Eur J Pharmacol; 2008 Jul; 589(1-3):1-7. PubMed ID: 18619590
[TBL] [Abstract][Full Text] [Related]
20. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
Somers-Edgar TJ; Rosengren RJ
Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
